EMAIL: mattl@mjbizdaily.com
PHONE: 720.699.0794

Matt Lamers

Matt is based in the Greater Toronto Area and covers international cannabis markets for Marijuana Business Daily. Previously, he worked as a business editor, photographer and reporter for newspapers and magazines in three countries, covering everything from the oil and gas industry in northern British Columbia to North Korean defectors in Seoul.


Articles by Matt Lamers :

Landmark Netherlands cannabis experiment set to begin this week

The Netherlands’ cannabis cultivation and distribution experiment is set to kick off Friday in what executives are calling a milestone for the industry in Europe – even though the supply-chain trial is starting years later than originally planned.

Image of the center of the city of Breda, Netherlands.

Why was the Ontario Cannabis Store sitting on a CA$500 million cash stockpile?

Ontario’s government-owned marijuana wholesaler was sitting on more than 500 million Canadian dollars ($367 million) in cash earlier this year, but officials have declined to spell out why the Ontario Cannabis Store held on to that much money rather than remit some of it back to the provincial government earlier.

Image of a 3D rendering of stacks of CA$100 bills.

Cannabis producer BZAM acquiring Final Bell Canada

Canadian cannabis producer BZAM entered into a definitive agreement to acquire Final Bell Canada from Final Bell Holdings International in an all-stock transaction, the companies announced Wednesday.

Image depicting M&A

Cannabinoid-based medicine Epidiolex approved for sale in Canada

Canada’s federal health regulator has approved Jazz Pharmaceuticals Canada’s cannabinoid-based medicine Epidiolex as an adjunctive therapy for certain rare and severe forms of epilepsy, allowing the company to bring to market a clinically tested drug with global sales that dwarf those of the nation’s entire medical cannabis industry

Image of a machine filling bottles with Epidiolex